CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 35.58
  • +0.70+2.01%
Market Closed Apr 25 15:00 CST
14.40BMarket Cap46.63P/E (TTM)

Runben Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-40.45%62.38M
-56.28%106.59M
-71.78%129.41M
-36.75%259.18M
--104.74M
-33.78%243.83M
--458.6M
60.55%409.79M
78.58%368.21M
--255.25M
Transactional financial assets
4,688.98%1.32B
6,473.32%1.25B
185.78%266.92M
61.76%134.6M
--27.64M
130.64%19M
--93.4M
-13.49%83.21M
-85.35%8.24M
--96.19M
Notes receivable and accounts receivable
73.48%21.44M
182.09%13.59M
86.91%15.78M
563.93%39.58M
--12.36M
303.46%4.82M
--8.44M
-19.43%5.96M
-49.03%1.19M
--7.4M
-Accounts receivable
73.48%21.44M
182.09%13.59M
86.91%15.78M
563.93%39.58M
--12.36M
303.46%4.82M
--8.44M
-19.43%5.96M
-49.03%1.19M
--7.4M
Other receivables (including interest and dividends)
190.59%7.14M
100.26%4.6M
-11.87%3.2M
75.46%3.87M
--2.46M
-61.30%2.3M
--3.63M
28.15%2.21M
326.97%5.94M
--1.72M
-Dividend receivable
----
----
----
----
----
----
--0
----
----
----
-Accrued interest receivable
----
----
----
----
----
----
--0
----
----
----
-Other receivable
----
----
----
75.46%3.87M
----
-61.30%2.3M
--3.63M
28.15%2.21M
326.97%5.94M
--1.72M
Advance payment
34.25%21.38M
38.24%11.49M
4.88%11.89M
-23.29%9.37M
--15.93M
8.61%8.31M
--11.34M
6.69%12.22M
-32.80%7.65M
--11.45M
Inventories
30.18%183.63M
27.62%118.57M
22.19%123.43M
23.68%166.25M
--141.06M
-9.54%92.91M
--101.02M
20.47%134.42M
80.52%102.71M
--111.58M
Other current assets
-96.99%43.74M
-93.24%90.91M
89,517.84%1.31B
14,180.24%1.3B
--1.45B
8,258.92%1.35B
--1.46M
15,178.26%9.1M
62.39%16.09M
--59.58K
Total current assets
-5.41%1.66B
-7.08%1.59B
174.05%1.86B
191.16%1.91B
--1.76B
236.51%1.72B
--677.88M
35.82%656.91M
48.12%510.04M
--483.64M
Non Current assets
Fixed assets
----
----
----
-4.23%249.57M
----
-3.55%254.86M
----
31.04%260.6M
38.76%264.24M
--198.87M
Constru in process
----
----
----
145.88%7.94M
----
-68.36%1.82M
----
-95.07%3.23M
-19.57%5.76M
--65.48M
Productive biological assets
----
----
----
----
----
----
--0
----
----
----
Intangible assets
191.49%54.19M
190.76%54.54M
-3.39%18.26M
-3.42%18.43M
--18.59M
-3.13%18.76M
--18.9M
-3.23%19.08M
-2.61%19.36M
--19.71M
Development expenditure
----
----
----
----
----
----
--0
----
----
----
Long deferred expense
-11.11%1.22M
-10.81%1.26M
-3.15%1.3M
-2.87%1.34M
--1.38M
--1.41M
--1.34M
--1.38M
----
----
Deferred tax assets
96.65%50.96M
112.46%44.23M
128.51%41.61M
82.14%40.81M
--25.92M
40.71%20.82M
--18.21M
79.73%22.41M
161.34%14.8M
--12.47M
Usufruct assets
-40.75%2.22M
-31.76%2.55M
-25.91%3.07M
-26.92%3.41M
--3.75M
-50.60%3.73M
--4.14M
-47.07%4.67M
-25.00%7.56M
--8.82M
Other non current assets
19,521.36%253.49M
22,731.65%256.9M
546.78%36.62M
----
--1.29M
-69.20%1.13M
--5.66M
7.87%3.42M
-94.69%3.65M
--3.17M
Total non current assets
108.22%638.06M
106.42%624.51M
16.80%360.68M
2.13%321.49M
--306.44M
-4.07%302.54M
--308.81M
2.03%314.77M
4.44%315.38M
--308.52M
Total assets
11.45%2.3B
9.93%2.22B
124.84%2.22B
129.93%2.23B
--2.07B
144.59%2.02B
--986.69M
22.66%971.68M
27.71%825.42M
--792.16M
Liabilities
Current liabilities
Notes payable and accounts payable
42.87%99.08M
15.98%61.14M
25.35%49.31M
82.01%134.53M
--69.35M
10.67%52.71M
--39.34M
-11.84%73.92M
2.72%47.63M
--83.84M
-Accounts payable
42.87%99.08M
15.98%61.14M
25.35%49.31M
82.01%134.53M
--69.35M
10.67%52.71M
--39.34M
-11.84%73.92M
2.72%47.63M
--83.84M
Contract liabilities
130.52%6.06M
123.92%13.37M
11.40%3.25M
-18.22%4.51M
--2.63M
32.51%5.97M
--2.92M
83.48%5.52M
7.18%4.5M
--3.01M
Salaries payable
7.11%10.44M
17.73%15.05M
19.82%12.98M
11.25%13.14M
--9.75M
18.18%12.78M
--10.83M
8.97%11.81M
48.13%10.82M
--10.84M
Taxs payable
124.67%46.87M
96.44%37.83M
53.42%33.94M
45.27%43.09M
--20.86M
-33.32%19.26M
--22.12M
-29.67%29.66M
207.70%28.88M
--42.18M
Other payable (including interest and dividends)
501.74%6.7M
316.20%6.67M
5,656.94%73.95M
10.69%1.28M
--1.11M
7.21%1.6M
--1.28M
-14.64%1.15M
-67.90%1.49M
--1.35M
-Dividend payable
--5.57M
--5.57M
--72.83M
----
----
----
----
----
----
----
-Other payable
----
----
--1.12M
10.69%1.28M
----
7.21%1.6M
----
-14.64%1.15M
22.85%1.49M
--1.35M
Non current liabilities due within one year
3.98%1.38M
-30.14%1.37M
-29.05%1.35M
-26.93%1.34M
--1.33M
-22.27%1.95M
--1.9M
-25.45%1.83M
4.75%2.51M
--2.46M
Other current liabilities
130.52%787.63K
110.67%1.77M
1.74%422.73K
17.00%846.53K
--341.68K
11.09%842.18K
--415.51K
44.71%723.52K
-36.57%758.09K
--499.99K
Total current liabilities
62.59%171.31M
44.22%137.19M
122.30%175.2M
59.48%198.74M
--105.36M
-1.53%95.12M
--78.81M
-13.56%124.62M
27.92%96.6M
--144.17M
Current liabilities
Deferred tax liabilities
-29.57%273.62K
-38.41%268.33K
-25.37%343.54K
-21.02%399.35K
--388.49K
-23.53%435.64K
--460.34K
3,295.05%505.65K
295.46%569.69K
--14.89K
Long term deferred income
40,243.69%4.27M
-22.64%8.67K
-21.43%9.31K
-54.82%9.94K
--10.58K
-95.87%11.21K
--11.85K
-96.70%22.01K
-75.91%271.51K
--667.83K
Lease liabilities
-56.45%1.06M
-30.58%1.42M
-29.70%1.76M
-32.75%2.11M
--2.45M
-62.13%2.04M
--2.51M
-53.02%3.13M
-31.80%5.39M
--6.67M
Other non current liabilities
----
----
----
----
----
----
--0
----
----
----
Total non current liabilities
97.08%5.61M
-31.91%1.69M
-29.00%2.12M
-31.27%2.52M
--2.84M
-60.08%2.49M
--2.98M
-50.20%3.66M
-32.08%6.23M
--7.35M
Total liabilities
63.50%176.92M
42.28%138.88M
116.79%177.32M
56.89%201.26M
--108.21M
-5.08%97.61M
--81.79M
-15.34%128.28M
21.42%102.83M
--151.52M
Shareholders equity
Paid-in capital
0.00%404.59M
0.00%404.59M
17.65%404.59M
17.65%404.59M
--404.59M
17.65%404.59M
--343.9M
0.00%343.9M
0.00%343.9M
--343.9M
Capital reserve funds
0.04%1.02B
0.06%1.02B
874.54%1.02B
876.45%1.01B
--1.01B
888.93%1.01B
--104.16M
1.76%103.94M
0.88%102.59M
--102.14M
Surplus reserve funds
34.35%65.77M
34.35%65.77M
75.76%62.62M
37.41%48.96M
--48.96M
37.41%48.96M
--35.63M
66.95%35.63M
66.95%35.63M
--21.34M
Retained profit
30.79%639.1M
31.28%594.9M
32.66%558.78M
56.81%564.41M
--488.63M
88.45%453.16M
--421.2M
107.75%359.93M
153.90%240.46M
--173.25M
Shareholders equity without minority interests
8.57%2.12B
8.29%2.08B
125.56%2.04B
141.03%2.03B
--1.96B
165.89%1.92B
--904.89M
31.65%843.41M
28.66%722.59M
--640.64M
Total shareholder equity
8.57%2.12B
8.29%2.08B
125.56%2.04B
141.03%2.03B
--1.96B
165.89%1.92B
--904.89M
31.65%843.41M
28.66%722.59M
--640.64M
Total liabilityies and equity
11.45%2.3B
9.93%2.22B
124.84%2.22B
129.93%2.23B
--2.07B
144.59%2.02B
--986.69M
22.66%971.68M
27.71%825.42M
--792.16M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Unqualified opinion
--
Auditor
--
Guangdong Sinong Accounting Firm (Special General Partnership)
--
--
--
Guangdong Sinong Accounting Firm (Special General Partnership)
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -40.45%62.38M-56.28%106.59M-71.78%129.41M-36.75%259.18M--104.74M-33.78%243.83M--458.6M60.55%409.79M78.58%368.21M--255.25M
Transactional financial assets 4,688.98%1.32B6,473.32%1.25B185.78%266.92M61.76%134.6M--27.64M130.64%19M--93.4M-13.49%83.21M-85.35%8.24M--96.19M
Notes receivable and accounts receivable 73.48%21.44M182.09%13.59M86.91%15.78M563.93%39.58M--12.36M303.46%4.82M--8.44M-19.43%5.96M-49.03%1.19M--7.4M
-Accounts receivable 73.48%21.44M182.09%13.59M86.91%15.78M563.93%39.58M--12.36M303.46%4.82M--8.44M-19.43%5.96M-49.03%1.19M--7.4M
Other receivables (including interest and dividends) 190.59%7.14M100.26%4.6M-11.87%3.2M75.46%3.87M--2.46M-61.30%2.3M--3.63M28.15%2.21M326.97%5.94M--1.72M
-Dividend receivable --------------------------0------------
-Accrued interest receivable --------------------------0------------
-Other receivable ------------75.46%3.87M-----61.30%2.3M--3.63M28.15%2.21M326.97%5.94M--1.72M
Advance payment 34.25%21.38M38.24%11.49M4.88%11.89M-23.29%9.37M--15.93M8.61%8.31M--11.34M6.69%12.22M-32.80%7.65M--11.45M
Inventories 30.18%183.63M27.62%118.57M22.19%123.43M23.68%166.25M--141.06M-9.54%92.91M--101.02M20.47%134.42M80.52%102.71M--111.58M
Other current assets -96.99%43.74M-93.24%90.91M89,517.84%1.31B14,180.24%1.3B--1.45B8,258.92%1.35B--1.46M15,178.26%9.1M62.39%16.09M--59.58K
Total current assets -5.41%1.66B-7.08%1.59B174.05%1.86B191.16%1.91B--1.76B236.51%1.72B--677.88M35.82%656.91M48.12%510.04M--483.64M
Non Current assets
Fixed assets -------------4.23%249.57M-----3.55%254.86M----31.04%260.6M38.76%264.24M--198.87M
Constru in process ------------145.88%7.94M-----68.36%1.82M-----95.07%3.23M-19.57%5.76M--65.48M
Productive biological assets --------------------------0------------
Intangible assets 191.49%54.19M190.76%54.54M-3.39%18.26M-3.42%18.43M--18.59M-3.13%18.76M--18.9M-3.23%19.08M-2.61%19.36M--19.71M
Development expenditure --------------------------0------------
Long deferred expense -11.11%1.22M-10.81%1.26M-3.15%1.3M-2.87%1.34M--1.38M--1.41M--1.34M--1.38M--------
Deferred tax assets 96.65%50.96M112.46%44.23M128.51%41.61M82.14%40.81M--25.92M40.71%20.82M--18.21M79.73%22.41M161.34%14.8M--12.47M
Usufruct assets -40.75%2.22M-31.76%2.55M-25.91%3.07M-26.92%3.41M--3.75M-50.60%3.73M--4.14M-47.07%4.67M-25.00%7.56M--8.82M
Other non current assets 19,521.36%253.49M22,731.65%256.9M546.78%36.62M------1.29M-69.20%1.13M--5.66M7.87%3.42M-94.69%3.65M--3.17M
Total non current assets 108.22%638.06M106.42%624.51M16.80%360.68M2.13%321.49M--306.44M-4.07%302.54M--308.81M2.03%314.77M4.44%315.38M--308.52M
Total assets 11.45%2.3B9.93%2.22B124.84%2.22B129.93%2.23B--2.07B144.59%2.02B--986.69M22.66%971.68M27.71%825.42M--792.16M
Liabilities
Current liabilities
Notes payable and accounts payable 42.87%99.08M15.98%61.14M25.35%49.31M82.01%134.53M--69.35M10.67%52.71M--39.34M-11.84%73.92M2.72%47.63M--83.84M
-Accounts payable 42.87%99.08M15.98%61.14M25.35%49.31M82.01%134.53M--69.35M10.67%52.71M--39.34M-11.84%73.92M2.72%47.63M--83.84M
Contract liabilities 130.52%6.06M123.92%13.37M11.40%3.25M-18.22%4.51M--2.63M32.51%5.97M--2.92M83.48%5.52M7.18%4.5M--3.01M
Salaries payable 7.11%10.44M17.73%15.05M19.82%12.98M11.25%13.14M--9.75M18.18%12.78M--10.83M8.97%11.81M48.13%10.82M--10.84M
Taxs payable 124.67%46.87M96.44%37.83M53.42%33.94M45.27%43.09M--20.86M-33.32%19.26M--22.12M-29.67%29.66M207.70%28.88M--42.18M
Other payable (including interest and dividends) 501.74%6.7M316.20%6.67M5,656.94%73.95M10.69%1.28M--1.11M7.21%1.6M--1.28M-14.64%1.15M-67.90%1.49M--1.35M
-Dividend payable --5.57M--5.57M--72.83M----------------------------
-Other payable ----------1.12M10.69%1.28M----7.21%1.6M-----14.64%1.15M22.85%1.49M--1.35M
Non current liabilities due within one year 3.98%1.38M-30.14%1.37M-29.05%1.35M-26.93%1.34M--1.33M-22.27%1.95M--1.9M-25.45%1.83M4.75%2.51M--2.46M
Other current liabilities 130.52%787.63K110.67%1.77M1.74%422.73K17.00%846.53K--341.68K11.09%842.18K--415.51K44.71%723.52K-36.57%758.09K--499.99K
Total current liabilities 62.59%171.31M44.22%137.19M122.30%175.2M59.48%198.74M--105.36M-1.53%95.12M--78.81M-13.56%124.62M27.92%96.6M--144.17M
Current liabilities
Deferred tax liabilities -29.57%273.62K-38.41%268.33K-25.37%343.54K-21.02%399.35K--388.49K-23.53%435.64K--460.34K3,295.05%505.65K295.46%569.69K--14.89K
Long term deferred income 40,243.69%4.27M-22.64%8.67K-21.43%9.31K-54.82%9.94K--10.58K-95.87%11.21K--11.85K-96.70%22.01K-75.91%271.51K--667.83K
Lease liabilities -56.45%1.06M-30.58%1.42M-29.70%1.76M-32.75%2.11M--2.45M-62.13%2.04M--2.51M-53.02%3.13M-31.80%5.39M--6.67M
Other non current liabilities --------------------------0------------
Total non current liabilities 97.08%5.61M-31.91%1.69M-29.00%2.12M-31.27%2.52M--2.84M-60.08%2.49M--2.98M-50.20%3.66M-32.08%6.23M--7.35M
Total liabilities 63.50%176.92M42.28%138.88M116.79%177.32M56.89%201.26M--108.21M-5.08%97.61M--81.79M-15.34%128.28M21.42%102.83M--151.52M
Shareholders equity
Paid-in capital 0.00%404.59M0.00%404.59M17.65%404.59M17.65%404.59M--404.59M17.65%404.59M--343.9M0.00%343.9M0.00%343.9M--343.9M
Capital reserve funds 0.04%1.02B0.06%1.02B874.54%1.02B876.45%1.01B--1.01B888.93%1.01B--104.16M1.76%103.94M0.88%102.59M--102.14M
Surplus reserve funds 34.35%65.77M34.35%65.77M75.76%62.62M37.41%48.96M--48.96M37.41%48.96M--35.63M66.95%35.63M66.95%35.63M--21.34M
Retained profit 30.79%639.1M31.28%594.9M32.66%558.78M56.81%564.41M--488.63M88.45%453.16M--421.2M107.75%359.93M153.90%240.46M--173.25M
Shareholders equity without minority interests 8.57%2.12B8.29%2.08B125.56%2.04B141.03%2.03B--1.96B165.89%1.92B--904.89M31.65%843.41M28.66%722.59M--640.64M
Total shareholder equity 8.57%2.12B8.29%2.08B125.56%2.04B141.03%2.03B--1.96B165.89%1.92B--904.89M31.65%843.41M28.66%722.59M--640.64M
Total liabilityies and equity 11.45%2.3B9.93%2.22B124.84%2.22B129.93%2.23B--2.07B144.59%2.02B--986.69M22.66%971.68M27.71%825.42M--792.16M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion----Unqualified opinion--
Auditor --Guangdong Sinong Accounting Firm (Special General Partnership)------Guangdong Sinong Accounting Firm (Special General Partnership)----Rong Cheng Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.61%
Sample Name
Sample Code
 +9.76%
Sample Name
Sample Code
 +9.67%
4
Nu Holdings
NU
+8.80%
5
Liberty Latin America-A
LILA
+8.14%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -